HanAll Biopharma Co. Ltd. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW115.45 |
Market Cap |
KRW1.43 T |
Shares Outstanding |
52.24 M |
Public Float |
29.44 M |
Address |
43 Sangseodang 1-gil Daejeon DE 34344 Korea, Republic Of |
Employees | - |
Website | http://www.hanall.co.kr |
Updated | 07/08/2019 |
HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceutical. Its products include medicine for digesting, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea. |